Skip to content

Comparing Outcomes of Labrum Preservation vs Excision in Primary Total Hip Arthroplasty

Labral Excision vs Preservation in Primary Total Hip Arthroplasty: A Prospective Randomized Controlled Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07812025
Enrollment
200
Registered
2026-09-10
Start date
2026-07-07
Completion date
2028-07-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty (THA)

Brief summary

This research is being done to determine whether removing or preserving the acetabular labrum, a ring of cartilage around the hip socket, during hip replacement surgery affects post-operative outcomes, operative time, or ease of placing the hip implant. Both techniques (labrum removal and labrum preservation) are commonly performed by surgeons during total hip arthroplasty (THA). However, there is no definitive evidence showing whether one approach is better than the other. The goal of this study is to compare recovery and surgical factors between these two routinely used methods.

Interventions

PROCEDURELabrum Preservation

The acetabular labrum will be left in place during surgery unless it physically prevents proper implant seating, in which case it may be trimmed as necessary.

PROCEDURELabrum Excision

The acetabular labrum will be removed during surgery, prior to final cup placement.

Sponsors

Total Joint Specialists
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years. * Indication for primary unilateral total hip arthroplasty for osteoarthritis (Tonnis grade ≥2 or surgeon's standard indication). * Able to provide informed consent and complete PROMs in English (or validated local language instruments).

Exclusion criteria

* Prior ipsilateral hip replacement or resurfacing. * Active infection or inflammatory arthritis where labral management is judged by the surgeon to be non-standard. * Severe acetabular bone loss or deformity requiring custom implants or complex reconstruction (Crowe III/IV dysplasia). * Planned simultaneous bilateral hip arthroplasty. * Preoperative heterotopic ossification. * Cognitive impairment preventing consent or completion of PROMs. * Patients for whom the surgeon believes leaving the labrum would be unsafe (e.g., gross interposed soft tissue preventing any reasonable cup placement without removal)

Design outcomes

Primary

MeasureTime frameDescription
Veterans RAND 12-Item Health Survey (VR-12) Physical Component Score (PCS)Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperativelyChange in physical health status measured by the Veterans RAND 12-Item Health Survey (VR-12), Physical Component Score. Scores range from 0 to 100, with higher scores indicating better physical health status. Compared between labrum excision and labrum preservation groups.
Veterans RAND 12-Item Health Survey (VR-12) Mental Component Score (MCS)Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperativelyChange in mental health status measured by the Veterans RAND 12-Item Health Survey (VR-12), Mental Component Score. Scores range from 0 to 100, with higher scores indicating better mental health status. Compared between labrum excision and labrum preservation groups.
Procedure Satisfaction (5-Point Likert Scale)12 weeks postoperativelyPatient-reported satisfaction with the surgical procedure, assessed via a 5-point Likert scale at 12 weeks postoperatively. Scores range from 1 (Very Dissatisfied) to 5 (Very Satisfied), with higher scores indicating greater satisfaction. Compared between labrum excision and labrum preservation groups.
Numeric Pain Rating Scale (NPRS)Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperativelyPatient-reported pain intensity measured by the Numeric Pain Rating Scale, an 11-point scale ranging from 0 to 10, with higher scores indicating worse (greater) pain. Compared between labrum excision and labrum preservation groups.
HOOS, JR. (Hip Disability and Osteoarthritis Outcome Score for Joint Replacement)Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperativelyChange in hip-specific patient-reported outcome measured by the Hip disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR.). Scores range from 0 to 100, with higher scores indicating better hip function and less disability. Compared between labrum excision and labrum preservation groups.
Forgotten Joint Score-12 (FJS-12)Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperativelyChange in joint awareness during daily activities measured by the Forgotten Joint Score-12 (FJS-12). Scores range from 0 to 100, with higher scores indicating better outcomes (less awareness of the joint, i.e., the joint is more "forgotten"). Compared between labrum excision and labrum preservation groups.
Intraoperative Soft-Tissue/Labral Interference with Cup PositionIntraoperative (at time of surgery)Surgeon-judged determination (yes/no) of whether soft tissue or the labrum interfered with acetabular cup positioning during the procedure, compared between groups.
Protocol Deviation Rate (Labral Removal in Preservation Arm)Intraoperative (at time of surgery)Incidence of labral removal in patients randomized to the labrum preservation arm, performed per the predefined protocol deviation criteria when needed for safe cup or liner seating. These cases remain in the intention-to-treat analysis and are also assessed in a per-protocol sensitivity analysis.
Operative TimeIntraoperative (at time of surgery)Total surgical time in minutes from skin incision to skin closure, recorded from the operative record and compared between labrum excision and labrum preservation groups.
Total Fluoroscopy TimeIntraoperative (at time of surgery)Total fluoroscopy time recorded during the surgical procedure, compared between labrum excision and labrum preservation groups.
Incidence of Supplemental Acetabular Screw UseIntraoperative (at time of surgery)Proportion of patients requiring supplemental acetabular screws for component fixation, compared between labrum excision and labrum preservation groups.
Estimated Blood Loss (EBL)Intraoperative (at time of surgery)Estimated intraoperative blood loss, compared between labrum excision and labrum preservation groups.

Secondary

MeasureTime frameDescription
Iliopsoas PainWithin 90 days postoperativelyIncidence of iliopsoas pain reported within 90 days after surgery, compared between labrum excision and labrum preservation groups.
Instability90 days and 1 year postoperativelyIncidence of postoperative hip instability, compared between labrum excision and labrum preservation groups.
Dislocation90 days and 1 year postoperativelyIncidence of postoperative hip dislocation, compared between labrum excision and labrum preservation groups.
Periprosthetic Joint Infection (PJI)90 days and 1 year postoperativelyIncidence of periprosthetic joint infection, compared between labrum excision and labrum preservation groups.
Reoperation90 days and 1 year postoperativelyIncidence of reoperation for any cause, compared between labrum excision and labrum preservation groups.
All-Cause Revision90 days and 1 year postoperativelyIncidence of revision surgery for any cause, compared between labrum excision and labrum preservation groups.
Wound Complications90 days and 1 year postoperativelyIncidence of postoperative wound complications, compared between labrum excision and labrum preservation groups.
Venous Thromboembolism (DVT/PE)90 days and 1 year postoperativelyIncidence of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, compared between labrum excision and labrum preservation groups.
Readmission90 days and 1 year postoperativelyIncidence of hospital readmission, compared between labrum excision and labrum preservation groups.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026